Oncology sits at the intersection of molecular science, clinical decision-making, and human resilience — where early diagnosis changes survival trajectories, where therapeutic protocols are constantly evolving, and where patient outcomes depend on both cutting-edge research and compassionate care. Kmed Journal of Oncology exists for the oncologists, surgical oncologists, and cancer researchers driving progress in this field every day.

We publish original research, clinical case reports, treatment outcome studies, prognostic analyses, and systematic reviews across the full breadth of oncological practice. Whether you are reporting survival outcomes from a new chemotherapy regimen, documenting a rare malignancy, or analyzing screening program effectiveness — if it advances how cancer is detected, treated, or prevented, it belongs here. Every submission undergoes rigorous peer review, and every published article is freely accessible to the global oncology community.

Scope & Focus Areas

We welcome submissions across all dimensions of cancer medicine, including:

• Medical Oncology — chemotherapy protocols, targeted therapies, immunotherapy, and treatment outcomes
• Surgical Oncology — oncologic resection techniques, margin analysis, lymph node dissection, and surgical outcomes
• Radiation Oncology — radiotherapy protocols, dose fractionation, treatment toxicity, and local control
• Gynecologic Oncology — ovarian, cervical, endometrial, and vulvar cancers
• Gastrointestinal Oncology — colorectal, gastric, esophageal, pancreatic, and hepatobiliary malignancies
• Thoracic Oncology — lung cancer, mesothelioma, and mediastinal tumors
• Hematologic Malignancies — leukemia, lymphoma, myeloma, and bone marrow transplant outcomes
• Head & Neck Oncology — oral, laryngeal, thyroid, and salivary gland cancers
• Breast Oncology — screening, surgical management, adjuvant therapy, and survivorship
• Urologic Oncology — prostate, bladder, renal, and testicular cancers
• Pediatric Oncology — childhood malignancies, treatment protocols, and long-term sequelae
• Neuro-Oncology — brain tumors, spinal cord malignancies, and neurological complications
• Cancer Screening & Early Detection — population-based screening, biomarker validation, and diagnostic algorithms
• Palliative & Supportive Care — symptom management, end-of-life care, and quality of life studies
• Cancer Epidemiology — incidence, prevalence, risk factors, and survival trends

Why Publish With Us

Open Access Your research reaches every oncologist, surgeon, and cancer researcher — without paywalls. Published articles are freely accessible worldwide from the date of publication.

Peer Review You Can Trust Every manuscript is reviewed by subject-matter experts in oncology, surgical oncology, and cancer research. We prioritize clinical relevance, methodological rigor, and patient-centered outcomes.

Fast Turnaround Initial editorial decision within 21 days. We understand that oncology research, clinical trials, and residency timelines operate on tight schedules.

Author-Centered Process Dedicated editorial support from submission through publication — with guidance on survival analysis, staging documentation, treatment protocols, and ethics approval for cancer research.

Indexed & Discoverable Published articles are optimized for discoverability, ensuring your treatment outcomes and research findings reach the oncologists and researchers who can apply and build on them.

Who Should Submit

Kmed Journal of Oncology is the right home for your work if you are a:

• DM Medical Oncology, DM Radiation Oncology, or MCh Surgical Oncology resident with treatment outcome data, case reports, or prognostic studies
• Practicing oncologist with original research, therapeutic innovations, or long-term follow-up data
• Surgeon, pathologist, or radiologist managing cancer patients and documenting diagnostic or treatment findings
• Faculty member or HOD in an Oncology department looking to build departmental research output and visibility
• Cancer researcher, epidemiologist, or palliative care specialist working on cancer-related investigations

If your work improves how cancer is detected, staged, treated, or managed through survivorship — this journal is for you.

Article Types Accepted

Type	Description
Original Research	Prospective or retrospective studies with primary oncologic data
Case Reports	Rare malignancies, unusual presentations, or diagnostic challenges
Case Series	Multiple cases illustrating treatment outcomes, toxicity patterns, or survival trends
Treatment Outcome Studies	Chemotherapy/radiotherapy efficacy, surgical margins, survival analysis, and toxicity reporting
Review Articles	Systematic, narrative, or scoping reviews of oncologic evidence
Prognostic Studies	Risk stratification, biomarker validation, and survival predictors
Short Communications	Preliminary findings, novel observations, or brief therapeutic insights
Letters to the Editor	Responses, perspectives, or brief oncologic commentaries

Submit Your Work

Every treatment protocol you refined, every survival curve you analyzed, every rare malignancy you diagnosed and managed — that clinical and research experience matters beyond your oncology unit. Published, it becomes a resource for every oncology resident designing treatment plans, every surgeon deciding on resection margins, and every researcher identifying gaps in cancer care.

Submit a Manuscript → View Author Guidelines → Contact the Editorial Team →